South-East Asia (WHO region) vs Turkmenistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage
South-East Asia (WHO region)
93.0%
in 2025
Turkmenistan
99.0%
in 2025
South-East Asia (WHO region) rank
1st
Turkmenistan rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- South-East Asia (WHO region)
- Turkmenistan
How they compare
Turkmenistan currently reports 99.0% against 93.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Turkmenistan's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 26 years both countries report, Turkmenistan has been ahead every year.
South-East Asia (WHO region) ranks 1st and Turkmenistan ranks 1st of 11 groups.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 94.5% | 90.3% | Turkmenistan |
| 2010s | 59.5% | 99.0% | 39.5% | Turkmenistan |
| 2020s | 88.3% | 98.8% | 10.5% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, South-East Asia (WHO region) or Turkmenistan?
- Turkmenistan, at 99.0% against 93.0% in South-East Asia (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between South-East Asia (WHO region) and Turkmenistan?
- 6.0%, with Turkmenistan ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Turkmenistan?
- 26 years are reported by both, from 2000 to 2025.
- How do South-East Asia (WHO region) and Turkmenistan rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- South-East Asia (WHO region) ranks 1st and Turkmenistan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.